Cantor Fitzgerald’s virtual panel on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”

  • April 27, 2021 - April 27, 2021
  • Virtual panel discussion

We are delighted to participate in a virtual panel discussion on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”, which will be hosted by Cantor Fitzgerald Equity Research on April 27 at 10:00AM ET.
Invited speakers from Biomica: Dr. Elran Haber , CEO and Dr. Shiri Meshner, VP R&D.

Back to all News

Highlighted News About Biomica

Microbiome Times Partnering Forum
Mar 17, 2025

Microbiome Times Partnering Forum

Biomica’s CEO, Dr. Elran Haber, is heading to Brussels this week for the Microbiome Times Partnering Forum – a key event for advancing microbiome-based therapeutics through strategic partnerships. More info & registration: www.microbiomeforum.com

Feb 27, 2025

MIXiii Health-Tech.IL 2025

Dr. Elran Haber, Biomica’s CEO, will attend MIXiii Health-Tech.IL 2025 on March 4-5 at ICC Jerusalem. This leading Israeli health-tech conference unites industry leaders, startups, and investors to explore innovations in personalized medicine, AI-driven drug development, cancer treatment, and more. More info & registration: www.mixiii.com